AL
MRTX

AJO LP’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

AJO LP’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,029
Closed -$391K – 693
2019
Q3 		$391K Buy
+5,029
New +$472K ﹤0.01% 501

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AJO LP's MRTX Position: Q4 2019 in Review

AJO LP sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2019, closing a stake of 5,029 shares — an estimated $391K sold.

AJO LP first reported a position in MRTX in Q3 2019 and held it in 1 quarter. The position peaked at $391K in Q3 2019. 190 funds tracked by Wall St. Rank hold MRTX as of Q4 2019.

  • AJO LP reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • AJO LP sold 5,029 Mirati Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $391K.
  • AJO LP first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • AJO LP's Mirati Therapeutics, Inc. Common Stock position peaked at $391K in Q3 2019.
  • 190 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2019.

Based on AJO LP's 13F filing for Q4 2019, filed 12 Feb 2020.